Microdosing vs SSRIs: What’s Happening in the Brain and Why It Matters

What We Explore in this Webinar:
‍

✔ What brain imaging (PET, fMRI) reveals about SSRIs vs microdosing

‍

✔ How psychedelics boost brain connectivity and neuroplasticity

‍

✔ Why Default Mode Network flexibility is key to emotional regulation

‍

✔ Microdosing’s potential to support depression, anxiety, and PTSD—especially when SSRIs fall short

‍

✔ The REBUS model: how psychedelics help unlock stuck mental patterns

‍

✔ Real-world implications for individuals and practitioners

‍

✔ Where research still needs to catch up—and how you can be part of the movement